NCT06219330View on ClinicalTrials.gov

Cathelicidin LL-37 Relation to Potentially Malignant Lesions

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

October 30, 2023

Study Completion Date

November 15, 2023

Conditions
Oral Potentially Malignant Lesions
Trial Locations (1)

Unknown

Sandy hassan shaaban, Cairo

All Listed Sponsors
collaborator

Cairo University

OTHER

lead

Fayoum University

OTHER